ABANDONED - EXPRESS
express
on 07 Oct 2024
Last Applicant/ Owned by
NL-1098 XH Amsterdam
NL
Serial Number
79374383 filed on 16th Jun 2023
Registration Number
N/A
Correspondent Address
Douglas T. Johnson
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
VECTORY
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutics Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Viral systems, gene therapy systems, nucleic acid delivery systems, namely, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in nucleic acid-based therapy, gene therapy and cell therapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79374383
Mark Type
No Service Mark
Attorney Docket Number
No 19250-0523
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Dec 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 16th Dec 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 07th Oct 2024 | ABANDONMENT - EXPRESS MAILED |
| 07th Oct 2024 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
| 30th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 23rd Apr 2024 | REFUSAL PROCESSED BY IB |
| 29th Mar 2024 | REFUSAL PROCESSED BY MPU |
| 29th Mar 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |